Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease – a secondary analysis of the randomized TWENTE trials
In the high-risk population of PCI patients with polyvascular disease, the presence of diabetes represents a profoundly significant additional risk factor at long-term follow-up, associated with significantly higher adverse event risks.<b>Trial registration:</b>ClinicalTrials.gov NCT01066650 NCT0133170 NCT01674803 NCT02508714.
Authors
- Eline H. Ploumen (ORCID: https://orcid.org/0000-0002-2689-3180)
- Peter W. Danse (ORCID: https://orcid.org/0000-0002-6240-361X)
- Paolo Zocca (ORCID: https://orcid.org/0000-0003-2726-480X)
- Adel Aminian (ORCID: https://orcid.org/0000-0002-4667-9181)
- Carine J.M. Doggen
- Rutger L. Anthonio
- Carl E. Schotborgh (ORCID: https://orcid.org/0000-0001-7630-0868)
- Clemens von Birgelen (ORCID: https://orcid.org/0000-0002-5128-2832)
- Rosaly A. Buiten (ORCID: https://orcid.org/0000-0002-7385-0634)
- Edouard Benit (ORCID: https://orcid.org/0000-0001-9691-7216)
- Tineke H. Pinxterhuis (ORCID: https://orcid.org/0000-0002-9050-8742)
- Ariel Roguin (ORCID: https://orcid.org/0000-0003-4628-1840)
- Marlies M. Kok (ORCID: https://orcid.org/0000-0003-0101-2217)
- Daphne van Vliet
Institutions
- Hillel Yaffe Medical Center (IL)
- Medisch Spectrum Twente (NL)
- Jessa Hospital (BE)
- Treant Zorggroep (NL)
- Haga Hospital (NL)
- Ziekenhuis Groep Twente (NL)
- Rijnstate Hospital (NL)
- Grand Charleroi Hospital (BE)
- University of Twente (NL)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2025-07-05
- DOI
- https://doi.org/10.1016/j.ijcha.2025.101741
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00